Our colleagues at the NIDDK Diabetic Foot Consortium have published the methodologic scaffolding the field has needed: a platform study—master-protocol trial design borrowed from oncology and COVID-19 vaccines—applied for the first time to DFU biomarker validation. Their mantra: No DFU Goes Unstudied.
The @NIDDKgov Diabetic Foot Consortium #ActAgainstAmputation @ALPSlimb @NIH
The NIDDK Diabetic Foot Consortium. This ongoing effort is critical to establishing a basis for measuring what we manage. Here's to Teresa Jones and colleagues for their leadership.The NIDDK Diabetic Foot Consortium - Teresa L.Z. Jones, Crystal M. Holmes, Aimee Katona, Catherine L. Martin, Monika A. Niewczas, Rodica Pop-Busui, Brian M. Schmidt, Chandan K. Sen,... Continue Reading →